FOR PREVIEW ONLY (Print)

Keith L. Black, MD

Chair, Department of Neurosurgery

Ruth and Lawrence Harvey Chair in Neuroscience

Director, Maxine Dunitz Neurosurgical Institute

Professor, Neurosurgery

Advanced Health Sciences Pavilion, A6600
127 S. San Vicente Blvd.
Los Angeles, CA 90048

Phone:

310-423-1773

Fax:

310-423-1008

Parking Instructions:

Validation available for Cedars-Sinai parking only. Nearest lot is Lot 4 on Sherbourne Drive.

Keith L. Black, MD

Chair, Department of Neurosurgery

Ruth and Lawrence Harvey Chair in Neuroscience

Director, Maxine Dunitz Neurosurgical Institute

Professor, Neurosurgery

  • Neurosurgery
  • Brain Tumor

Acoustic Neuromas

Astrocytoma

Brain Cancers (Glioma)

Brain Stem Glioma

Brain Tumors

Cavernous Angioma

Cerebellopontine Angle Syndrome

Colloid Cysts

Ependymomas

Glioblastoma Multiforme

Hemangioblastomas

Intraventricular Tumors

Meningiomas

Neuroblastomas

Neuromas

Oligodendrogliomas

Orbital Tumors

Pineal Tumors

Pituitary Tumors

Schwannoma

Skull Base Tumors

Spine Tumors (Cervical, Thoracic, Lumbar, Sacral)

Show moreShow less

The research of Keith L Black, MD, focuses on biology of blood-brain barrier (BBB) and biochemical modulation of the blood-brain tumor barrier (BTB), targeted drug delivery, tumor immunology, cancer vaccines, cancer stem cells, microwave tumor ablation, nanotechnology for drug delivery, optical guided surgery for brain tumors, and Alzheimer's retinal imaging.

View NIH Biographical Sketch as a PDF

  • Medical School: University of Michigan School of Medicine, 1981
  • Internship: University of Michigan School of Medicine, 1982
  • Residency: University of Michigan School of Medicine, 1987

View CV as a PDF

  • Editorial Board: Public Library of Science (PLoS), Current
  • America's Top Doctors and Best Doctors in America, 2007, Current
  • Cedars-Sinai Pioneer in Medicine Award, 2018
  • Whitney M. Young, Jr. Living Legend Award, National Urban League, 2011
  • Special Recognition, National Academy of Science, 2000
  • Jacobs Javitz Award, NIH National Institute of Neurological Disorders and Stroke, 2000
  • Golden Plate Award, American Academy of Achievement, 1999
  • Cover of Time Magazine, "Heroes of Medicine", 1997
  • American Academy of Neurological Surgery, 1995
  • Neurosurgical Society of America, 1993
  • American Association of Neurological Surgeons, 1991
  • Congress of Neurological Surgeons, 1982

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Sun T, Patil R, Galstyan A, Klymyshyn D, Ding H, Chesnokova A, Cavenee W, Furnari F, Ljubimov V, Shatalova E, Wagner S, Li D, Mamelak AN, Bannykh S, Patil CG, Rudnick J, Hu J, Grodzinski Z, Rekechenetskiy A, Falahatian V, Lyubimov A, Leoh LS, Chen YM, Daniels-Wells T, Penichet P, Holler E, Ljubimov A, Black KL, Ljubimova JY. Blockade of a laminin-411 - Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment crosstalk. Cancer Res 2019 Jan 18. pii: canres.2725.2018. doi: 10.1158/0008-5472.CAN-18-2725.
  • Kittle D, Vasefi F, Patil CG, Mamelak AN, Black KL, Butte PV. Real time optical Biopsy: Time-resolved Fluorescence Spectroscopy instrumentation and validation. Scientific Reports. 2016 Dec 8;6:38190. doi: 10.1038/srep38190
  • Chou S, Gangalum PR, Patil P, Cavenee WK, Furnari F, Galstyan A, DingH, Chesnokova A, Mashouf A, Fox I, Black KL, Holler E, Ljubimov AV, Ljubimova. JY. Simultaneous blockade of CK2 and EGFR pathways by tumor-targeted nanobioconjugates significantly improves therapeutic efficacy against glioblastoma multiforme. J Control Release. 244 (2016) 14-23. doi: 10.1016/j.jconrel.2016.11.001.
  • Butte PV, Mamelak AN, Parrish-Novak J, Drazin D, Shweikeh F, Gangalum PR, Chesnokova A, Ljubimova JY, Black KL. Near-infrared imaging of brain tumors using the Tumor PaintTM BLZ-100 to achieve near-complete resection of brain tumors. Neurosurg Focus. 2014;36(2):E1.
  • Jeswani S, Nuno M, Folkerts V, Mukherjee D, Black KL, Patil CG. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis. Neurosurgery. 2013;73(2):240-246.
  • Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuno MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, et al. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother. 2013;62(1):125-135.
  • Wheeler CJ, Black KL. Vaccines for glioblastoma and high-grade glioma. Expert Rev Vaccines. 2011;10(6):875-886.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Keith L. Black, MD